These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13957201)

  • 1. A study of quadruple D.P.T.--polio vaccine (Quad) in Regina school children, November, 1960.
    JACKSON FI; DILLENBERG HO; RAMSAY JD
    Can J Public Health; 1963 Apr; 54():169-75. PubMed ID: 13957201
    [No Abstract]   [Full Text] [Related]  

  • 2. SMALLPOX, DIPHTHERIA, TETANUS, PERTUSSIS, AND POLIOMYELITIS IMMUNIZATION.
    GODDARD JL
    JAMA; 1964 Mar; 187():1009-12. PubMed ID: 14102936
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccination in infancy with oral poliomyelitis vaccine and diphtheria, tetanus, pertussis vaccine.
    BENSON PF; BUTLER NR; COSTELLO JM; URQUHART J; BARR M; GOFFE AP; KNIGHT GJ; POLLOCK TM
    Br Med J; 1963 Mar; 1(5331):641-3. PubMed ID: 13967520
    [No Abstract]   [Full Text] [Related]  

  • 4. FACTORS INVOLVED IN THE STABILITY OF PERTUSSIS COMPONENT IN QUADRUPLE DPT-POLIO VACCINE.
    PONTECORVO M
    Riv Ist Sieroter Ital; 1964; 39():464-9. PubMed ID: 14259054
    [No Abstract]   [Full Text] [Related]  

  • 5. FURTHER OBSERVATIONS ON VACCINATION IN INFANCY WITH ORAL POLIOMYELITIS VACCINE AND DIPHTHERIA, TETANUS, PERTUSSIS VACCINE.
    BUTLER NR; BENSON PF; URQUHART J; GOFFE AP; KNIGHT GJ; POLLOCK TM
    Br Med J; 1964 Aug; 2(5406):418-20. PubMed ID: 14160241
    [No Abstract]   [Full Text] [Related]  

  • 6. [ANTIBODY FORMATION AFTER 3 DOSES OF QUADRUPLE VACCINE INJECTION FOLLOWED BY TRIVALENT ORAL POLIOMYELITIS VACCINE].
    HENIGST W; MUELLER F
    Dtsch Med Wochenschr; 1965 Aug; 90():1502-6. PubMed ID: 14344415
    [No Abstract]   [Full Text] [Related]  

  • 7. CURRENT IMMUNIZATION METHODS AND PRECAUTIONS.
    WEHRLE PF
    Calif Med; 1964 Sep; 101(3):153-9. PubMed ID: 14199083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [STATISTICO-CLINICAL DATA ON THE USE OF THE COMBINED DIPHTHERIA-PERTUSSIS-TETANUS-POLIOVIRUS VACCINE IN INFANTS].
    GIURANNA U
    Pediatria (Napoli); 1963; 71():962-7. PubMed ID: 14125501
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE COMBINATION OF TRIPLE ANTIGEN (PERTUSSIS-DIPHTHERIA-TETANUS) AND ANTIPOLIOMYELITIS VACCINATION IN THE INFANT].
    MARTINDUPAN R; GEISENDORF W; PACCAUD M; KOECHLI B; GMUR L
    Ann Paediatr; 1963; 201():95-107. PubMed ID: 14046076
    [No Abstract]   [Full Text] [Related]  

  • 10. A DIPHTHERIA-TETANUS-POLIOMYELITIS VACCINE.
    DANE DS; DICK GW; HAIRE M; BRIGGS EM; CONNOR TJ
    Lancet; 1965 Apr; 1(7391):877-9. PubMed ID: 14272681
    [No Abstract]   [Full Text] [Related]  

  • 11. TABTD-POLIO VACCINE. IMMUNIZATION OF RECRUITS WITH A COMBINED VACCINE CONTAINING DIPHTHERIA AND TETANUS TOXOIDS, TAB AND POLIOMYELITIS VACCINE.
    BARRON RD; SELLERS AH; BROWN MH; WILSON RJ; MOLONEY PJ; WARDLAW AC; WEBER JC; MACLEOD DR
    Can J Public Health; 1963 Nov; 54():493-9. PubMed ID: 14079117
    [No Abstract]   [Full Text] [Related]  

  • 12. Diphtheria and tetanus toxoids combined with pertussis and poliomyelitis vaccines. Clinical trial of a quadruple antigen.
    WILSON RJ; MOSS GW; POTTER FC; MACLEOD DR
    Can Med Assoc J; 1959 Sep; 81(6):450-3. PubMed ID: 13845125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-poliomyelitis effectiveness and tolerance of a new combined vaccine. Aluminum oxide adsorbate vaccine against poliomyelitis, diphtheria and tetanus].
    KARTE H; GRAFE A
    Dtsch Med Wochenschr; 1962 Oct; 87():2147-51. PubMed ID: 13962616
    [No Abstract]   [Full Text] [Related]  

  • 14. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
    Vesikari T; Van Damme P; Lindblad N; Pfletschinger U; Radley D; Ryan D; Vuocolo S; Haupt RM; Guris D
    Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological response in the infant vaccinated with quadruple DPT-polio vaccine].
    MORRONE G; NUNZIATA B; PICCIOTTO L
    Riv Ist Sieroter Ital; 1959; 34():321-9. PubMed ID: 14424398
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunitary response of the infant vaccinated with quadruple DPT-polio vaccine].
    MORRONE G; NUNZIATA B; PICCIOTTO L
    Riv Ist Sieroter Ital; 1959; 34():321-9. PubMed ID: 14424397
    [No Abstract]   [Full Text] [Related]  

  • 20. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.